These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7696894)

  • 1. [The suppression of the cerebrovascular constrictor effects of malondialdehyde by GABA-ergic substances].
    Mirzoian SA; Akopian VP; Manukian AA
    Eksp Klin Farmakol; 1994; 57(5):16-7. PubMed ID: 7696894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurochemical control of cerebral blood circulation].
    Mirzoian SA
    Farmakol Toksikol; 1983; 46(4):5-15. PubMed ID: 6311614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The cerebral vasoconstrictor effects of malondialdehyde].
    Mirzoian SA; Mkrtchian SL; Manukian AA
    Eksp Klin Farmakol; 1993; 56(4):18-9. PubMed ID: 8220006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of GABA and piracetam on cerebral circulation and the neurogenic mechanisms of its regulation].
    Ivashev MN; Petrov VI; Shcherbakova TN
    Farmakol Toksikol; 1984; 47(6):40-3. PubMed ID: 6519254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [GABA-ergic component of the cerebrovascular effects of sodium hydroxybutyrate].
    Mirzoian RS; Gan'shina TS
    Biull Eksp Biol Med; 1981 Oct; 91(10):456-8. PubMed ID: 7317607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of pyrrolidone-2 on the cerebral circulation].
    Mirzoian SA; Ordian MB; Balasanian MG
    Biull Eksp Biol Med; 1987 Jan; 103(1):64-5. PubMed ID: 3801653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of a drug composition containing pyroglutamic acid and pyrrolidone on the cerebral circulation].
    Lun'shina EV; Gan'shina TS; Mirzoian RS
    Eksp Klin Farmakol; 2002; 65(3):3-5. PubMed ID: 12227092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of 2-pyrrolidone and gamma-butyrolactone on the rate of 14C-leucine incorporation into the proteins of different brain structures and of their arterial tissues].
    Mirzoian SA; Zalinian MG; Gevorkian GA; Topchian AV; Balasanian MG
    Biull Eksp Biol Med; 1988 Nov; 106(11):571-2. PubMed ID: 3196858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dopaminergic component in the mechanism of action of gamma-aminobutyric acid derivatives and structural analogs].
    Allikmets LKh; Polevoĭ LG; Tsareva TA; Zharkovskiĭ AM
    Farmakol Toksikol; 1979; 42(6):603-6. PubMed ID: 499466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of action of piracetam on cerebral circulation].
    Akopian VP; Balian LS
    Farmakol Toksikol; 1987; 50(1):38-41. PubMed ID: 3556550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [GABA-ergic cortical component in the action of piracetam and cetyl GABA].
    Ostrovskaia RU; Molodavkin GM; Kovalev GI
    Biull Eksp Biol Med; 1982 Apr; 93(4):62-4. PubMed ID: 7082805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of GABA isonicotinoylamide on cerebral circulation].
    Mirzoian RS; Gan'shina TS; Shmuĭlovich LM
    Biull Eksp Biol Med; 1981 Nov; 92(11):573-4. PubMed ID: 7317636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [GABA-ergic mechanisms of the cerebrovascular effects of fenazepam and diazepam].
    Gan'shina TS
    Biull Eksp Biol Med; 1980 Oct; 90(10):439-42. PubMed ID: 7426706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroprotective and cerebrovascular effects of GABA mimetics].
    Mirzoian RS
    Eksp Klin Farmakol; 2003; 66(2):53-6. PubMed ID: 12962049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of lithium derivatives of GABA on blood circulation and metabolic indices in the brain under ischemia].
    Pogorelyĭ VE; Gaevyĭ MD; Migruev RR; Ivashev MN
    Eksp Klin Farmakol; 1995; 58(5):19-21. PubMed ID: 8704581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of the cerebrovascular effect of piracetam].
    Mirzoian RS; Gan'shina TS
    Biull Eksp Biol Med; 1985 Jan; 99(1):64-6. PubMed ID: 3967075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cerebrovascular and antiaggregative effects of GABA-docosahexaenoyldopamine conjugate].
    Kurdiumov IN; Gan'shina TS; Mirzoian NR; Vasil'eva TM; Makarov VA; Petrukhina GN; Bezuglov VV; Gretskaia NM; Zinchenko GN; Mirzoian RS
    Eksp Klin Farmakol; 2008; 71(4):26-9. PubMed ID: 18819437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional-behavioral profile of new cyclic GABA analogs in acute toxicity tests].
    Bugaeva LI; Spasov AA; Verovskiĭ VE
    Eksp Klin Farmakol; 2004; 67(3):61-5. PubMed ID: 15341073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regulating effect of gamma-aminobutyric acid and pyrrolidone-2 on endogenous blood metalloproteins with anti- and pro-oxidant activity in hypoxia].
    Manukian AA; Simonian MA; Simonian RM; Simonian GM
    Eksp Klin Farmakol; 2004; 67(1):28-31. PubMed ID: 15079905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the mesocortical dopamine neurons.
    Fuxe K; Hökfelt T; Agnati L; Johansson O; Ljungdahl A; Perez de la Mora M
    Adv Biochem Psychopharmacol; 1977; 16():47-55. PubMed ID: 883552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.